Related Experiment Video
Updated: Nov 1, 2025

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Benzodiazepines increase the likelihood of both infectious and thrombotic complications
Edward Skicki1, Madison Morgan, Catherine Brown
1From the Trauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, Pennsylvania.
Introduction:
Benzodiazepines (BZDs) modulate peripheral γ-amino-butyric acid type A on macrophages causing immunomodulation. They inhibit proinflammatory cytokines increasing infections. Prior studies have also shown that infections can increase thrombotic complications. We sought to examine this relationship in trauma patients. We hypothesized that the presence of BZDs on admission urine drug screen (UDS) would increase rates of both complications.
Methods:
All patients submitted to the Pennsylvania Trauma Outcome Study database from 2003 to 2018 were queried. Those with a positive UDS for BZDs were analyzed. Infectious complications were defined as pneumonia, urinary tract infection, sepsis, wound, and soft tissue infection, and thrombotic complications were defined as presence of pulmonary embolism or deep vein thrombosis. Logistic regressions controlling for demographic and injury covariates assessed the adjusted impact of BZDs on infectious and thrombotic complications.
Results:
A total of 3,393 patients (2.08%) had infectious complications, and 3,048 (1.87%) had thrombotic complications. Furthermore, 33,260 patients (20.4%) had a positive UDS for BZDs on admission. Univariate analysis showed that those positive for BZDs had higher rates of infectious (3.33% vs. 1.76%, p < 0.001) and thrombotic (2.84% vs. 1.62%, p < 0.001) complications. Multivariate analysis revealed that BZDs significantly increased the odds of infectious and thrombotic complications. Patients who tested positive for BZDs and subsequently developed infection had increased odds (adjusted odds ratio, 1.65; p < 0.001) of developing thrombotic complications.
Conclusion:
Trauma patients with a positive UDS for BZDs had higher odds of both infectious and thrombotic complications. Moreover, odds of thrombotic complications were higher in those with infections.
Level Of Evidence:
Epidemiological, level III.
Insights
Benzodiazepines (BZDs) in trauma patients increase the risk of infectious and thrombotic complications. Infections in these patients further elevate the likelihood of thrombotic events, highlighting a critical link between BZD use and adverse outcomes.
Area of Science:
- Immunology
- Trauma Surgery
- Pharmacology
Background:
- Benzodiazepines (BZDs) modulate immune responses by inhibiting proinflammatory cytokines, potentially increasing infection risk.
- Infections are known to elevate the risk of thrombotic complications.
- The combined impact of BZDs and infection on trauma patient outcomes requires investigation.
Purpose of the Study:
- To investigate the association between benzodiazepine (BZD) use and the incidence of infectious and thrombotic complications in trauma patients.
- To determine if infections in BZD-positive trauma patients further increase thrombotic complication rates.
Main Methods:
- Retrospective analysis of the Pennsylvania Trauma Outcome Study database (2003-2018).
- Inclusion of trauma patients with positive urine drug screens (UDS) for BZDs.
- Logistic regression models were used to assess the impact of BZDs on infectious and thrombotic complications, controlling for covariates.
Main Results:
- Patients with BZDs on admission UDS showed significantly higher rates of both infectious (3.33% vs. 1.76%) and thrombotic (2.84% vs. 1.62%) complications.
- Multivariate analysis confirmed that BZDs significantly increased the odds of both infectious and thrombotic complications.
- Trauma patients with BZDs who developed infections had 1.65 times higher odds of experiencing thrombotic complications.
Conclusions:
- Benzodiazepine (BZD) use in trauma patients is associated with increased odds of infectious and thrombotic complications.
- Infectious complications in BZD-positive trauma patients further elevate the risk of thrombotic events.
More Related Videos
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antihypertensive Drugs: Thiazide-Class Diuretics

